Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)

A 43‐year‐old female with multiple sclerosis developed urethral melanoma. The only potential risk factor was treatment with natalizumab, a humanized monoclonal antibody against α4 integrins. To investigate the risk‐exposure relationship, we reviewed this case, all other published cases, and cases of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Sabol, Rachel A., Noxon, Virginia, Sartor, Oliver, Berger, Joseph R., Qureshi, Zaina, Raisch, Dennis W., Norris, LeAnn B., Yarnold, Paul R., Georgantopoulos, Peter, Hrushesky, William J., Bobolts, Laura, Ray, Paul, Lebby, Akida, Kane, Robert C., Bennett, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504343/
https://ncbi.nlm.nih.gov/pubmed/28635055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados